GlaxoSmithKline PharmaceuticalsGLAXO 
$34.42-0.85%24h
-0.85%24h
Global rank2495
Market cap$5.83B
Change 7d-1.59%
YTD Performance51.49%
SP500 benchmarkOutperform
P/E0.95
P/S15.04
Revenue$387.65M
Earnings$72.80M
Dividend yield-
Main Sector
Healthcare
Category
GlaxoSmithKline Pharmaceuticals GLAXO Total Debt
GLAXO Total Debt in 2022: $411.93K
According to GlaxoSmithKline Pharmaceuticals latest financial reports the total debt is $411.93K, an decrease of -54.67% to 2022. At the end of 2022 company had $908.82K total debt. This figure represents the debts and financial obligations that GlaxoSmithKline Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
GlaxoSmithKline Pharmaceuticals GLAXO Total Debt History from 2023 to 2022
-
Value:-
GLAXO Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $411.93K | -54.67% |
| 2022 | $908.82K | -62.35% |
| 2021 | $2.41M | -24.61% |
| 2020 | $3.20M | 15075.82% |
| 2019 | $21.10K | - |
View the Top Total Debt Stocks 
